Mesenteric injury after cardiopulmonary bypass: Role of poly(adenosine 5′-diphosphate-ribose) polymerase

Critical Care Medicine

Volumn 32, Issue 12, 2004, Pages 2392-2397

  Szabó, Gábor ^a,b   Soós, Pál ^a,b   Mandera, Susanne ^a   Heger, Ulrike ^a   Flechtenmacher, Christa ^a   Seres, Leila ^b   Zsengellér, Zsuzsanna ^c   Sack, Falk Udo ^a   Szabó, Csaba ^b,c   Hagl, Siegfried ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c INOTEK CORPORATION   (United States)

Author keywords

Cardioplegia; Cardiopulmonary bypass; Heart surgery; Mesenteric injury; Poly(adenosine 5 diphosphate ribose) polymerase; Reperfusion injury

Indexed keywords

ACETYLCHOLINE; CREATINE KINASE; INO 1001; LACTIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NITROPRUSSIDE SODIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; DRUG EFFECT; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTION; HEMODYNAMICS; HYPOTHERMIA; MESENTERY; MESENTERY BLOOD FLOW; MESENTERY DISEASE; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; REPERFUSION; VASCULAR RESISTANCE; VASODILATATION;

ANIMALS; BIOPSY, NEEDLE; CARDIOPULMONARY BYPASS; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART ARREST, INDUCED; HEMODYNAMIC PROCESSES; IMMUNOHISTOCHEMISTRY; MESENTERY; MYOCARDIAL REPERFUSION INJURY; POLY(ADP-RIBOSE) POLYMERASES; PROBABILITY; RANDOM ALLOCATION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 10644254743     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000148009.48919.6A     Document Type: Article

References (32)

1. Edmunds LH Jr: Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1998; 66:S12-S16
2. Wallace A, Lam HW, Nose PS, et al: Changes in systolic and diastolic ventricular function with cold cardioplegic arrest in man. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. J Card Surg 1994; 9:497-502
3. Wan S, LeClerc JL, Vincent JL: Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies. Chest 1997; 112:676-692
4. Cameron D: Initiation of white cell activation during cardiopulmonary bypass: Cytokines and receptors. J Cardiovasc Pharmacol 1996; 27(Suppl 1):S1-S5
5. Morse DS, Adams D, Magnani B, et al: Platelet and neutrophil activation during cardiac surgical procedures: Impact of cardiopulmonary bypass. Ann Thorac Surg 1998; 65:691-695
6. Andrási TB, Buhmann V, Soós P, et al: Mesenteric complications after hypothermic cardiopulmonary bypass with cardiac arrest: Underlying mechanisms. Artificial Organs 2002; 26:943-946
7. Ng CSH, Wan S, Yim APC, et al: Pulmonary dysfunction after cardiac surgery. Chest 2002; 121:1269-1277
8. Tuttle KR, Worall NK, Dahlstrom LR, et al: Predictors of ARF after cardiac surgical procedures. Am J Kidney Dis 2003; 41:76-83
9. Byhahn C, Strouhal U, Martens S, et al: Incidence of gastrointestinal complications in cardiopulmonary bypass patients. World J Surg 2001; 25:1140-1144
10. Thorén A, Jakob SM, Pradl R, et al: Jejunal and gastric mucosal perfusion versus splanchnic blood flow and metabolism: An observational study on postcardiac surgical patients. Crit Care Med 2000; 28:3649-2654
11. Simic O, Strathausen S, Hess W, et al: Incidence and prognosis of abdominal complications associated with cardiopulmonary bypass. Cardiovasc Surg 1999; 7:419-424
12. Klempnauer J, Grothues F, Bektas H, et al: Acute mesenteric ischemia following cardiac surgery. J Cardiovasc Surg 1997; 38:639-643
13. Andrási TB, Soós P, Bakos G, et al: L-arginine protects the mesenteric vascular circulation against cardiopulmonary bypass-induced vascular dysfunction. Surgery 2003; 134:72-79
14. Virág L, Szabó C: The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002; 54:375-429
15. Szabó G, Liaudet L, Hagl S, et al: Poly(ADP-ribose) polymerase activation in the reperfused myocardium. Cardiovasc Res 2004; 61:471-480
16. Szabó C, Zingarelli B, O'Connor M, et al: DNA strand breakage, activation of poly-ADP ribosyl synthase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci U S A 1996; 93:1753-1758
17. Szabó C, Cuzzocrea S, Zingarelli B, et al: Endothelial dysfunction in a rat model of endotoxin shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Invest 1997; 100:723-735
18. Szabó G, Buhmann V, Andrási TB, et al: Poly-ADP-ribose polymerase (PARP)-inhibition protects against myocardial and endothelial reperfusion injury after hypothermic cardiac arrest. J Thorac Cardiovasc Surg 2003; 126:651-658
19. Szabó G, Soós P, Bährle S, et al: Role of poly (ADP-ribose) polymerase activation in the pathogenesis of cardiopulmonary dysfunction in a canine model of cardiopulmonary bypass. Eur J Cardiothorac Surg, In Press
20. Komjáti K, Mabley JG, Virag L, et al: Poly-(ADP-ribose) polymerase inhibition protect neurons and the white matter and regulates the translocation of apoptosis-inducing factor in stroke. Int J Mol Med 2004; 13:373-382
21. Khan TA, Ruel M, Bianchi C, et al: Poly(ADP-ribose) polymerase inhibition improves post-ischemic myocardial function after cardioplegia-cardiopulmonary bypass. J Am Coll Surg 2003; 197:270-277
22. Institute of Laboratory Animal Resources: Guide for the Care and Use of Laboratory Animals (NIH Publication No. 86-23). National Institutes of Health, Bethesda, MD, 1996
23. Szabó G, Bährle S, Stumpf N, et al: Poly (ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res 2002; 90:100-106
24. Sack FU, Dollner R, Reidenbach B, et al: Extracorporeal circulation induced microvascular perfusion injury of the small bowel. Eur Surg Res 2002; 34:418-424
25. Sack FU, Reidenbach B, Schledt A, et al: Dopexamine attenuates microvascular perfusion injury of the small bowel in pigs induced by extracorporeal circulation. Br J Anaesth 2002; 88:841-847
26. Tofukuji M, Stahl GL, Metais C, et al: Mesenteric dysfunction after cardiopulmonary bypass: role of complement C5a. Ann Thorac Surg 2000; 69:799-807
27. Akata T, Yoshitake J, Nakashima M, et al: Effects of protamine on vascular smooth muscle of rabbit mesenteric artery. Anesthesiology 1991; 75:833-846
28. Ohri SK, Bowles CW, Mathie RT, et al: Effects of cardiopulmonary bypass protocols on gut tissue oxygenation and blood flow. Ann Thorac Surg 1997; 64:163-170
29. Sellke FW, Boyle EM Jr, Verrier ED: Endothelial cell injury in cardiovascular surgery: The pathophysiology of vasomotor dysfunction. Ann Thorac Surg 1996; 62:1222-1228
30. Cuzzocrea S, Zingarelli B, Constantino G, et al: Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br J Pharmacol 1997; 121:1065-1074
31. Liaudet L, Szabó A, Soriano FG, et al: Poly-(ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia. Shock 2000; 14:134-141
32. Mazzon E, Dugo L, De Sarro A, et al: Beneficial effects of GPI 6150, an inhibitor of poly(ADP-ribose) polymerase in a rat model of splanchnic artery occlusion and reperfusion. Shock 2002; 17:222-227